Infectious Diseases Products & Services

Our advanced rapid diagnostic products platforms will help healthcare practitioners and government officials make earlier, more effective treatment decisions and improve outcomes for patients. Rapid™ Screen early detection field assay and automated lab equipment give medical professionals the monitoring tools necessary in today’s volatile environment. Rapid™ Screen provides actionable information required to provide therapeutic intervention against emerging Superbugs.

Products Under Development

Bioterrorism:

Yersinia Pestis/Bubonic Plague

Smallpox/Variola

Botulism Clostridium

Tularemia

Ricin 

Nosocomial Infections:

Screening before admittance in emergency room.

Carbapenem-resistant Enterobacteriaceae

Methicillin-resistant S.aureus

C. Difficile

S. pneumoniae

Mycodacterium Tuberculosis

Salmonella Typhimurium

Infectious Disease:

Malaria

Hepatitis C 

Hepatitis B  

Zika

MCR1

Emerging SuperBugs

Post Exposure Prophylaxis:
Dyne Immune is also pursuing translational medicine efforts to address and treat life-threatening diseases to address public health needs.

Post exposure prophylaxis (PEP) systems contract development of remediation tools in the event exposure. PEP for immediate, passive immunity. Dyne Immune is prepared to provide PEP to remediate any and all pathogens.